At enrollment, all patients underwent comprehensive physical examinations, including assessment of clinical symptoms of malaria and neurological examinations. Microscopic examinations of thick and thin blood smears confirmed the presence of Plasmodium species and its corresponding load. Adverse drug reactions were monitored and recorded. If vomiting occurred within 1 hour of taking the drug, the drug was readministered. Patients were hospitalized for 7 days or until malaria symptoms disappeared or the parasites cleared. All patients were followed up weekly from the start of treatment to the 28th day. If any discomfort occurred during the follow-up, patients could return to the hospital for additional follow-up.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.